Adam Marcus named interim executive director of Winship Cancer Institute of Emory University

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Adam Marcus was named interim executive director of Winship Cancer Institute of Emory University.

Marcus will assume the role from Walter J. Curran, Jr., while Emory University conducts a national search for Winship’s next executive director.

“We are very fortunate that Dr. Curran will support Dr. Marcus from now until his departure in late January,” Jonathan S. Lewin, executive vice president for health affairs at Emory University and CEO and chair of the board for Emory Healthcare, said in a statement. “They will work together over the next five weeks to ensure a smooth transition in Winship leadership in its research, educational, and clinical missions.”

An advisory committee, with representation from across the Woodruff Health Sciences Center, including Winship leaders, will oversee the executive director search.

Curran, who is also the Lawrence W. Davis Professor and chair of the Department of Radiation Oncology, announced in October that he would be stepping down from his Emory leadership roles to serve as the global chief medical officer of GenesisCare, an international health care provider. He was the first and only radiation oncologist to direct an NCI-designated cancer center.

Marcus, a member of Winship’s executive leadership team and a fellow of the Woodruff Leadership Academy, serves as the associate director for basic research and shared resources at Winship. He is a professor of hematology and medical oncology and holds the Winship 5K Professorship. Marcus is also the scientific director of the Emory Integrated Cellular Imaging Core, one of the Emory Integrated Core Facilities.

Marcus’ research focuses on cancer metastasis, drug development, and image-guided genomics, and he has been continuously funded by NIH since joining the Emory faculty in 2006. He is a principal investigator of five active NIH grants, including a multi-PI R25 Science Education Partnership Award that supports Citizen Science HD. Marcus co-leads Citizen Science HD, an outreach program that provides opportunities for underrepresented learners in STEM.

Table of Contents

YOU MAY BE INTERESTED IN

In this episode of The Cancer Letter Podcast, Fran Visco, president of the National Breast Cancer Coalition, and Jacquelyn Cobb, managing editor of The Cancer Letter, discuss the Metastatic Breast Cancer Act, bipartisan legislation that would eliminate the waiting periods for Social Security Disability Insurance and Medicare for eligible people with metastatic breast cancer. 
Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login